AURASH KHOOBEHI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SLIDELL, LA NPI 1548535883
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology LA Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$3,676.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 140
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,067.17 across 33 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,067.17 | 33 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $183.88 | 4 |
| Acerta Pharma LLC | $164.99 | 3 |
| BeiGene USA, Inc. | $128.40 | 1 |
| ABBVIE INC. | $97.60 | 1 |
| Daiichi Sankyo Inc. | $95.19 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $51.28 | 2 |
| Astellas Pharma US Inc | $42.13 | 2 |
| Gilead Sciences, Inc. | $33.12 | 2 |
| Merck Sharp & Dohme Corporation | $30.01 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.70 | 1 |
| Stemline Therapeutics Inc. | $21.92 | 1 |
| Exelixis Inc. | $21.15 | 1 |
| Genentech USA, Inc. | $20.01 | 1 |
| Lilly USA, LLC | $19.99 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.98 | 1 |
| Sumitomo Pharma America, Inc. | $18.25 | 1 |
| Tempus AI, Inc | $18.24 | 1 |
| PFIZER INC. | $17.85 | 1 |
| Incyte Corporation | $16.51 | 1 |
| SHIELD THERAPEUTICS INC | $15.59 | 1 |
| EMD Serono, Inc. | $14.51 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.87 | 1 |
By program year
Records — PY2024 (33)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.